Thyroid remnant ablation with 1110MBq of 131I in outpatients: measurement of effective dose to household members and establishment of safety precautions

被引:0
|
作者
Yoshimura, M. [1 ]
Tsutsui, H. [2 ]
Ikeda, N. [2 ]
Koizumi, K. [3 ]
机构
[1] Tokyo Med Univ, Dept Radiol, Tokyo 1600023, Japan
[2] Tokyo Med Univ, Dept Thorac & Thyroid Surgey, Tokyo 1600023, Japan
[3] Tokyo Med Univ, Hachioji Med Ctr, Dept Radiol, Tokyo 1600023, Japan
关键词
Thyroid neoplasms; Ablation techniques; Outpatients; RADIATION-EXPOSURE; CARCINOMA; CANCER; THERAPY;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim. The aim of this study was to establish and confirm the safety of administering 1110MBq of I-131 to outpatients. Methods: Total radiation exposure from patients to household members was hypothesized from the measured dose rate at 1 m when the patient is released. Actually we also measured the effective dose to household members who assisted outpatients during the first 7 days after the administration of I-131 by personal dosimeter. A list of radiation safety precautions is given to the patient and household members. Behavioral reports about the distances and times of close contact throughout the 7 days are requested of each household member. Results: The effective dose measured using the personal dosimeter to all household members employing several safety precautions was confirmed to be lower than the hypothesized dose calculated using our formula. And the mean whole-body effective dose rate over the 7 days in household members was 0.05 +/- 0.08 (range, 0.05 to 0.43) mSv, which specify that radiation exposure to household members of the outpatients who have just received ablative radiation therapy must be below 5.0 mSv/event. Conclusion: Remnant thyroid ablation with 1110MBq for outpatients showed that the radiation doses to household members were within the recommended constraint dose according to several safety precautions. The method of returning home after remnant thyroid ablation is thought to be the most important factor that determines the effective dose to household members of outpatients.
引用
收藏
页码:101 / 108
页数:8
相关论文
共 12 条
  • [1] Thyroid remnant ablation in outpatients with 1.1GBq of I-131: measurement of effective dose to caregivers and establishment of safety precautions
    Uchida, K.
    Yoshimura, M.
    Koizumi, K.
    Tokuuye, K.
    Tsutsui, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S321 - S322
  • [2] Ablation efficacy of 3600 MBq, 131I In treatment of thyroid remnant
    Takavar, A
    Eftekhari, M
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S356 - S357
  • [3] Thyroid remnant ablation with 1.1 GBq of 131I for outpatients
    Suzuki, K.
    Tsutsui, H.
    Suzuki, A.
    Yoshimura, M.
    Hashimoto, T.
    Uchida, K.
    Koizumi, K.
    Tokuuye, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S430 - S431
  • [4] Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer
    Doi, SAR
    Woodhouse, NJY
    CLINICAL ENDOCRINOLOGY, 2000, 52 (06) : 765 - 773
  • [5] Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post-surgical 131I ablation therapy for differentiated thyroid carcinoma
    Cherk, Martin H.
    Kalff, Victor
    Yap, Kenneth S. K.
    Bailey, Michael
    Topliss, Duncan
    Kelly, Michael J.
    CLINICAL ENDOCRINOLOGY, 2008, 69 (06) : 957 - 962
  • [6] Clinical Observation of High Dose 131I for Remnant Thyroid Tissue Ablation
    易济民
    曾理
    莫逸
    肿瘤基础与临床, 2008, (03) : 240 - 242
  • [7] Predictive factors for the outcome of I-131 1110MBq ablation therapy in the patients with differentiated thyroid cancer: urinary iodine, serum thyroglobulin, and uptake to thyroid bed
    Ito, S.
    Iwano, S.
    Kato, K.
    Naganawa, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S600 - S601
  • [8] Low Dose (1850 MBq) Versus High Dose (3700 MBq) of 131I in Ablation Therapy of Thyroid Remnants in Patients with Low Risk Differentiated Thyroid Carcinoma
    Andres Gracia, A.
    Rambalde Pecheco, E.
    Tardin Cardoso, L.
    Ayala Perez, S.
    Razola Alba, P.
    Cancer Garza, L.
    Lopez Acosta, M.
    Prats Rivera, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S537 - S537
  • [9] An indirect high iodine (131I) effective dose used for thyroid ablation in patients with thyroid cancer. Is the method of measurement important?
    Al-Shakhrah, Issa A.
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2020, 21 (07): : 173 - 180
  • [10] Lowest effective 131I activity for thyroid remnant ablation of differentiated thyroid cancer patients Dosimetry-based model for estimation
    Jentzen, W.
    Moldovan, A. -S.
    Ruhlmann, M.
    Goerges, R.
    Bockisch, A.
    Rosenbaum-Krumme, S.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2015, 54 (03): : 137 - 143